Table S1 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer

Authors :: David Planchard
Bo H. Chao
Rebecca R. Hozak
Ling Gao
Sameera R. Wijayawardana
Huzhang Mao
Dae Ho Lee
Joo-Hang Kim
Keunchil Park
Pilar Garrido
Ki Hyeong Lee
James Chih-Hsin Yang
Luis G. Paz-Ares
Helena A. Yu
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Dose Adjustments

Full Text Access

Tools